Showing results (111-120 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|June 19, 2024
Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?Sang Youn Hwang, Sangjune L Lee, Hongqun Liu, et al.
Liver Cancer|May 16, 2024
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-UpÁngeles García-Criado, Jordi Rimola, Susana Seijo, et al.
Liver Cancer|May 16, 2024
Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver ResectionNa Reum Kim, Heejin Bae, Hyeo Seong Hwang, et al.
Liver Cancer|December 19, 2025
Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre StudyYing Zhou, Haiqing Wang, Jiayi Wu, et al.
Liver Cancer|June 24, 2026
Real-World Treatment Patterns and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma: Results from the OREIOS StudyStephen Lam Chan, Valeriy Breder, Yu-Yun Shao, et al.
Liver Cancer|July 31, 2026
Real-World Evidence from a Nationwide Prospective Study of the Efficacy/Safety of Systemic Therapy for Unresectable Hepatocellular Carcinoma: First 1,000 Patients of the PRISM StudyMasafumi Ikeda, Shinji Itoh, Daisuke Onozuka, et al.
Liver Cancer|August 8, 2026
The Regeneration Paradox in Liver Cancer: How Chronic Injury Transforms Healing into CarcinogenesisChun-Nan Yeh, Miin-Fu Chen
Liver Cancer|January 14, 2021
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Liver Cancer|March 1, 2019
Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort StudyHyo Jeong Kang, Farhan Haq, Chang Ohk Sung, et al.
Liver Cancer|March 1, 2019
Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic FeaturesHyungjin Rhee, Chansik An, Hye-Young Kim, et al.
Pageof 55